Sundaram Multi Pap Ltd

Sundaram Multi Pap Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 21 October 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Sundaram Multi Pap Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 21 October 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Sundaram Multi Pap Ltd’s shares declined to a fresh 52-week low of Rs.1.57 on 20 Jan 2026, marking a significant downturn amid broader market fluctuations and company-specific performance issues.

Sundaram Multi Pap Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 21 October 2024. However, the analysis and financial metrics presented here reflect the stock’s current position as of 19 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Sundaram Multi Pap Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 21 October 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Sundaram Multi Pap Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 21 October 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Sundaram Multi., a microcap company in the miscellaneous sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The recent assessment highlights concerns across multiple parameters, signalling caution for investors amid a backdrop of sustained underperformance and operational difficulties.

Sundaram Multi Pap has reached a new 52-week low of Rs.1.61 today, marking a significant decline amid a persistent downward trend. The stock has recorded losses over the past five consecutive sessions, reflecting ongoing pressures within the miscellaneous sector despite a broadly positive market environment.

Sundaram Multi Pap has reached a new 52-week low of Rs.1.61, marking a significant decline as the stock continues its downward trajectory. This fresh low comes amid a series of losses over the past week, reflecting ongoing pressures within the miscellaneous sector.

Sundaram Multi Pap has reached a new 52-week low of Rs.1.61 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past five consecutive sessions, reflecting ongoing pressures within the company’s financial performance and market positioning.

Sundaram Multi Pap Ltd., a micro-cap player in the paper stationery industry with a market capitalisation of ₹90.00 crores, has reported its second consecutive quarter of positive earnings, but the celebration remains muted. The company's stock, trading at ₹1.89 as of November 14, 2025, continues to languish near its 52-week low of ₹1.68, reflecting investor scepticism about the sustainability of this nascent recovery.

Sundaram Multi Pap has hit a new 52-week low, reflecting significant market challenges. The stock has declined 34.44% over the past year, contrasting with the Sensex's gains. Key performance indicators show a negative trend in operating profits and weak debt servicing ability, raising concerns about its long-term viability.

Sundaram Multi Pap has reached a new 52-week low of Rs. 1.72, reflecting significant underperformance in the market. The stock has declined consecutively over two days and has fallen 30.86% over the past year, contrasting with the Sensex's gains. Financial metrics indicate ongoing challenges for the company.

Sundaram Multi Pap has reached a new 52-week low of Rs. 1.78, reflecting a significant decline and underperformance compared to its sector. The stock has fallen consecutively over two days, with a notable annual decline. Financial metrics indicate ongoing challenges, including negative growth in operating profits and low return on equity.

Sundaram Multi Pap Ltd, a microcap in the miscellaneous sector, reached its upper circuit limit today, trading at Rs 2.20. The stock saw significant activity with a total volume of approximately 37.43 lakh shares and a turnover of Rs 0.79 crore, indicating strong market interest.